Objective: To address a significant gap in research and clinical practice by developing the global conceptual definition of Sarcopenia. Methodology: Study design; Two-phase Delphi study with participants from leading international musculoskeletal organisations and sarcopenia societies [1]. A steering committee was formed of representatives from each continent/region (Asia, Europe, North America, South America, New Zealand/Australia). The steering committee then developed a glossary of research terms on sarcopenia [2]. Following this, a list of statements on critical aspects of sarcopenia was developed and finalised. Participants: Invitations to complete an online survey were sent to international experts from academic, industry, and healthcare professions. All participants including steering committee members completed a declaration of interest form prior to participation. Statistical analysis: Prespecified criteria were set by the steering committee including a two-phase study design and an acceptable threshold of > 80% for accepted statements
An executive summary on the Global conceptual definition of Sarcopenia / Kirk, Ben; Cawthon, Peggy M.; Arai, Hidenori; Ávila-Funes, José A.; Barazzoni, Rocco; Bhasin, Shalender; Binder, Ellen F.; Bruyère, Olivier; Cederholm, Tommy; Chen, Liang-Kung; Cooper, Cyrus; Duque, Gustavo; Fielding, Roger A.; Guralnik, Jack; Kiel, Douglas P.; Landi, Francesco; Reginster, Jean-Yves; Sayer, Avan A.; Visser, Marjolein; von Haehling, Stephan; Woo, Jean; Cruz-Jentoft, Alfonso J.; Global Leadership Initiative in Sarcopenia (GLIS), Group. - In: AGING CLINICAL AND EXPERIMENTAL RESEARCH. - ISSN 1720-8319. - ELETTRONICO. - 36:1(2024), pp. 153."-"-153."-". [10.1007/s40520-024-02798-4]
An executive summary on the Global conceptual definition of Sarcopenia
Barazzoni, Rocco;
2024-01-01
Abstract
Objective: To address a significant gap in research and clinical practice by developing the global conceptual definition of Sarcopenia. Methodology: Study design; Two-phase Delphi study with participants from leading international musculoskeletal organisations and sarcopenia societies [1]. A steering committee was formed of representatives from each continent/region (Asia, Europe, North America, South America, New Zealand/Australia). The steering committee then developed a glossary of research terms on sarcopenia [2]. Following this, a list of statements on critical aspects of sarcopenia was developed and finalised. Participants: Invitations to complete an online survey were sent to international experts from academic, industry, and healthcare professions. All participants including steering committee members completed a declaration of interest form prior to participation. Statistical analysis: Prespecified criteria were set by the steering committee including a two-phase study design and an acceptable threshold of > 80% for accepted statements| File | Dimensione | Formato | |
|---|---|---|---|
|
2024 Kirk.pdf
accesso aperto
Tipologia:
Documento in Versione Editoriale
Licenza:
Creative commons
Dimensione
665.43 kB
Formato
Adobe PDF
|
665.43 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


